Search results
Pediatric thalassemia: How does thalassemia affect children?
Medical News Today· 2 days agoThalassemia is an inherited disease that affects the blood. Children with severe thalassemia will...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 22 hours agoThe newer assets in its portfolio are growing in prominence. These include Reblozyl, a treatment for anemia in patients with beta-thalassemia first...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 4 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Motley Fool via Yahoo Finance· 2 days agoMeanwhile, the commercial launch of Casgevy, as a one-time functional cure for sickle cell disease...
Low-income Floridians with sickle cell disease will have access to new gene therapies
Florida Phoenix via Yahoo News· 7 days agoQuality Journalism for Critical Times Raising a child with sickle cell disease during the 1990s,...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoVertex and partner Crispr Therapeutics gained Food and Drug Administration approval for a...
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 4 days agoWe recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo Finance· 6 days agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Editas Medicine, Inc. (NASDAQ:EDIT) Short Interest Update
ETF DAILY NEWS· 5 days agoEditas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) saw a large growth in short interest in May. As of May 31st, there was short interest totalling 22,020,000 shares, a growth of 6.1% from ...
In drug-pricing debate, Mass. gene-therapy drugmakers make their case - Boston Business Journal
The Business Journals· 2 days agoWhen a new gene therapy to treat a deadly rare disease called metachromatic leukodystrophy was approved earlier this year, the first thing on Maria Kefalas’ mind wasn’t the price. Kefalas' daughter ...